{
    "clinical_study": {
        "@rank": "30150", 
        "arm_group": [
            {
                "arm_group_label": "Lidocaine", 
                "arm_group_type": "Experimental", 
                "description": "Paracervical block using 15 mL of 1 % lidocaine"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "paracervical block using 15 mL of bacteriostatic saline"
            }
        ], 
        "brief_summary": {
            "textblock": "Despite the high efficacy of intrauterine devices (IUDs), some women choose not to receive\n      IUDs secondary to the pain associated with insertion. Nulliparous women may be especially\n      susceptible to procedure-related pain from IUD insertion. This study will investigate the\n      difference in perceived pain from IUD insertion, comparing local anesthesia to a placebo,\n      among women who have not had a vaginal delivery before. The investigators anticipate that\n      among women who have not had a previous vaginal delivery, the pain associated with IUD\n      insertion will be significantly decreased after administration of local anesthesia."
        }, 
        "brief_title": "Study of Local Anesthesia as a Method to Decrease IUD Insertion Related Pain", 
        "condition": [
            "IUD Insertion Complication", 
            "Pain Control"
        ], 
        "detailed_description": {
            "textblock": "The study will investigate the difference in perceived pain from IUD insertion, comparing\n      paracervical block with lidocaine to a placebo (bacteriostatic saline) block, among\n      nulliparous and \"functionally nulliparous\" women. The investigators plan a double-masked,\n      placebo controlled, randomized clinical trial. The investigators anticipate that among\n      patients who have not had a previous vaginal delivery, the pain associated with IUD\n      insertion will be significantly decreased after administration of a 15 mL 1% lidocaine\n      paracervical block compared to patients who receive 15 mL of bacteriostatic saline\n      (placebo)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Nulliparous and \"functionally nulliparous\" women receiving their first IUD.\n             \"Functionally nulliparous\" women include those who have never had a prior vaginal\n             delivery or who have never experienced previous significant cervical dilation (ie.\n             women who have experienced miscarriages or abortions prior to 24 weeks gestation, and\n             women who have had cesarean sections while not in active labor defined as <4 cm\n             dilation).\n\n          -  English speaking\n\n        Exclusion Criteria:\n\n          -  Presence of a Centers for Disease Control Medical Eligibility Criteria for\n             Contraceptive Use category 3 or 4 precaution to a levonorgestrel IUD\n\n          -  chronic narcotic use, current or past history of illegal drug use (excluding\n             marijuana)\n\n          -  allergy to lidocaine"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01967017", 
            "org_study_id": "NA_00078756"
        }, 
        "intervention": {
            "arm_group_label": "Lidocaine", 
            "intervention_name": "Lidocaine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Lidocaine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Intrauterine device", 
            "Paracervical block"
        ], 
        "lastchanged_date": "October 17, 2013", 
        "location": {
            "contact": {
                "last_name": "Nell Molano, CRNP", 
                "phone": "410-874-1455"
            }, 
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21224"
                }, 
                "name": "Johns Hopkins Bayview Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Paracervical Block With Lidocaine as a Modality to Decrease IUD Insertion Related Pain", 
        "other_outcome": {
            "description": "The degree of difficulty of insertion as rated by the provider will be compared between groups.", 
            "measure": "Ease of insertion", 
            "safety_issue": "No", 
            "time_frame": "Within 15 minutes of IUD insertion"
        }, 
        "overall_contact": {
            "email": "rjamshi1@jhmi.edu", 
            "last_name": "Roxanne Jamshidi, MD", 
            "phone": "410-550-0336"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Differences in visual analog scale (VAS) measurements of perceived pain at the time of IUD deployment", 
            "measure": "Pain at time of IUD insertion", 
            "safety_issue": "No", 
            "time_frame": "During IUD insertion (no further follow up after patient leaves ofice)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01967017"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johns Hopkins University", 
            "investigator_full_name": "Roxanne Jamshidi", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Intrapersonal and group differences in VAS measurements of expected pain and other time points", 
            "measure": "Pain at other time points of pelvic exam", 
            "safety_issue": "No", 
            "time_frame": "During other steps of pelvic exam up to 15b minutes after IUD inserted (no further follow up after patient leaves office)"
        }, 
        "source": "Johns Hopkins University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johns Hopkins University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}